The Centre for Blood Transplant and Cell Therapies (CBTCT) brings together the largest allogeneic stem cell transplant units in Australia with a focus on identifying transplant and cell therapy strategies to reduce graft versus host disease and improve patient and disease outcomes after transplant. In this webinar series, investigators from the CBTCT will review major topics in stem cell transplantation and cell therapy, highlighting how the activities of the CBTCT are addressing current challenges in stem cell transplantation. In the third seminar of this series, Professor James Ferrara will outline research highlighting biomarkers in graft vs host disease and the role of the MAGIC Consortium, while Dr Siok Tey will review novel cellular therapies for the treatment of graft vs host disease.
Professor James Ferrara - Tisch Cancer Institute, Icahn School of Medicine at Mt Sinai
Dr Siok Tey - Royal Brisbane and Womens Hospital / QIMR Berghofer Medical Research Institute
When: Thursday 3 September 2020, 8am AEST
Link to webinar: https://uni-sydney.zoom.us/j/92998014030
Link to CBTCT website for all webinar recordings:
For the PDF flyer, click here
Haematology Society of Australia and New Zealand (HSANZ)
145 Macquarie Street, Sydney NSW 2000
Tel: 02 8097 8114
Copyright © 2020 Haematology Society of Australia & New Zealand (HSANZ). All Rights Reserved.